Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Biology » Physiology » Aerobic Exercise: Health Benefits, Types and Common Misconceptions Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Famous Discoverers and Explorers of America
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Exercise Intervention in Treatment-Resistant Major Depressive Disorder: Benefits of Accelerometer Monitoring (pp. 113-136)
Tell A Friend
Tell someone you know about this product.
Exercise Intervention in Treatment-Resistant Major Depressive Disorder: Benefits of Accelerometer Monitoring (pp. 113-136) $0.00
Authors:  (Jorge Mota-Pereira, Jose Carlos Ribeiro, Daniela Fonte, Serafim Carvalho, Joaquim Ramos, Jorge Silverio, Psychosocial Rehabilitation Department, Hospital Magalhaes Lemos, Porto, Portugal, and others)
Although there are several reports on the benefits of exercise on Major Depressive
Disorder, none has monitored these exercise programs with accelerometers. We have
conducted a 12 week home based moderate intensity exercise program in 33 treatmentresistant
Major Depressive Disorder patients and, based on accelerometer data,
determined compliance, exercise patterns and relationship between time spent in MVPA,
response to treatment and Quality of Life. Patients were diagnosed according to DSM-IV
criteria, and, from 150 initially screened, 33 met study criteria and were included. Four
patients were excluded due to non-compliance/drop-out, thus a total of 29 patients
finished the study. Patients were randomized either to a moderate intensity exercise
program, which consisted of 30-45 min/day walks, 5 days/week, for 12 weeks, plus usual
pharmacotherapy (N=22) or regular daily activities plus usual pharmacotherapy (N=11).
All participants wore an ActiGraph® GT1M accelerometer during the 12 weeks.
Moderate to very vigorous physical activity (MVPA), HAMD17, BDI, GAF, CGI-S,
WHOQOL-Bref and SF-36 were assessed. Results show a trend for increasing time spent
in MVPA from no response to response and remission (p = 0.028), and medium to strong
correlations between time spent in MVPA and better depression and functioning
parameters. There was also a trend for increasing time spent in MVPA and improvement
of some QoL domains, namely WHOQOL-Bref Physical domain and SF-36 Physical
Functioning and General Health Domains (p < 0.05). Participants showed preference for
exercising on weekdays and on specific periods of the day (p < 0.05). Therefore, we
suggest that future implementation of effective exercise augmentation therapy programs
in MDD patients should consider objective measures that allow the quantification of
exercise and assessment of exercise patterns. 

Available Options:

  Open Access item.
  Click below PDF icon for free download.


This is an Open Access item. Click above PDF icon for free download.
Special Focus Titles
01.Peter Singer’s Ethics: A Critical Appraisal
02.Sexism: Past, Present and Future Perspectives
03.Body and Politics: Elite Disability Sport in China
04.Childhood and Adolescence: Tribute to Emanuel Chigier, 1928-2017
05.Renal Replacement Therapy: Controversies and Future Trends
06.Food-Drug Interactions: Pharmacokinetics, Prevention and Potential Side Effects
07.Terrorism and Violence in Islamic History and Theological Responses to the Arguments of Terrorists
08.International Event Management: Bridging the Gap between Theory and Practice
09.The Sino-Indian Border War and the Foreign Policies of China and India (1950-1965)
10.Tsunamis: Detection, Risk Assessment and Crisis Management
11.Sediment Watch: Monitoring, Ecological Risk Assessment and Environmental Management
12.Self-Regulated Learners: Strategies, Performance, and Individual Differences

Nova Science Publishers
© Copyright 2004 - 2018

Exercise Intervention in Treatment-Resistant Major Depressive Disorder: Benefits of Accelerometer Monitoring (pp. 113-136)